 Thomas M. Lietman, MD
Professor in Residence
Director, WHO Collaborating Center
Contact Information
95 Kirkham Box 0412
San Francisco, CA 94143-0412
Phone: 415-476-1442
Education
MD: College of Physicians and Surgeons, Columbia University
Residency: The Wilmer Ophthalmological Institute, Johns Hopkins University
Fellowship: The F.I. Proctor Foundation, University of California San Francisco
Research Interests - INTERNATIONAL STUDIES
Dr. Thomas Lietman is investigating what community-treatment strategies are most effective against trachoma. He is constructing mathematical models to determine who within communities need to be targeted, how often communities need to be treated, and whether the World Health Organization’s antibiotic treatment program is in danger of generating significant drug resistance. He is conducting clinical trials that evaluate the long term effect of mass antibiotic treatment of trachoma to determine if infectious trachoma can, indeed, be eliminated with repeat community antibiotic treatment. These studies are in the Gurage and Amhara Zones of Ethiopia, in areas where approximately one-half of the children in a village may have active trachoma infection. Dr. Lietman is also the principal investigator on a project to study the use of steroids in bacterial cornea ulcers in South India, and is setting up a fungal ulcer trial in the same location.
Representative Publications
Gaynor BD, Miao Y, Cevallos V, Jha H, Chaudary JS, Bhatta R, Osaki-Holm S, Yi E, Schachter J, Whitcher JP, Lietman T. Eliminating trachoma in areas with limited disease. Emerg Infect Dis. 2003. 9(5):596-8.
Bird M, Dawson CR, Schachter JS, Miao Y, Shama A, Osman A, Bassem A, Lietman TM. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? J Infect Dis. 2003. 187(10):1669-73. Epub 2003 Apr 30.
Kuo IC, Cevallos V, Troyer R, Lietman TM, McLeod SD. Efficacy of transport media use versus direct inoculation of blood agar plates in the microbiologic evaluation of experimental Streptococcus pneumoniae keratitis. Cornea. 2003. 22(3):249-53.
Schiedler V, Bhatta RC, Miao Y, Bird M, Jha H, Chaudary JS, Fry AM, Lietman TM. Pattern of antibiotic use in a trachoma-endemic region of Nepal: implications for mass azithromycin distribution. Ophthalmic Epidemiol. 2003. 10(1):31-6.
Gaynor BD, Holbrook KA, Whitcher JP, Holm SO, Jha HC, Chaudhary JS, Bhatta RC, Lietman T. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. Br J Ophthalmol. 2003. 87(2):147-8.
Gaynor BD, Yi E, Lietman T. Rationale for mass antibiotic distribution for trachoma elimination. Int Ophthalmol Clin. 2002. 42(1):85-92. Review. No abstract available.
Thein J, Zhao P, Liu H, Xu J, Jha H, Miao Y, Pizzarello L, Tapert L, Schachter J, Mabon M, Osaki-Holm S, Lietman T, Paxton A. Abstract Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma? Ophthalmic Epidemiol. 2002. 9(4):263-9.
Alrawi AM, Chern KC, Cevallos V, Lietman T, Whitcher JP, Margolis TP, Cunningham ET Jr. Biotypes and serotypes of Haemophilus influenzae ocular isolates. Br J Ophthalmol. 2002. 86(3):276-7.
Diamant J, Benis R, Schachter J, Moncada J, Pang F, Jha HC, Bhatta RC, Porco T, Lietman T. Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic Epidemiol. 2001. 8(2-3):109-17.
Naseri A, McLeod SD, Lietman T. Evaluating the human optical system: corneal topography and wavefront analysis. Ophthalmol Clin North Am. 2001. 14(2):269-73, vii. Review.
Holm SO, Jha HC, Bhatta RC, Chaudhary JS, Thapa BB, Davis D, Pokhrel RP, Yinghui M, Zegans M, Schachter J, Frick KD, Tapert L, Lietman TM. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bull World Health Organ. 2001. 79(3):194-200. Epub 2003 Jul 07.
Complete
Medline Listing |
